The Research and Development Division develops modern forms of drug, performs their patent clearance assessment and medical evaluation. Our activity in the field of R&D also includes the organization and performance of clinical trials. Within the pharmacovigilance system, we monitor the safety of pharmacotherapy. The convenience and availability of our own R&D laboratories and our own clinical trials centre in addition to continuous cooperation with universities and research centres ensures the high quality of the developed pharmaceutical technologies, analytical methods, clinical trials and authorization documentation.

We perform a wide range of research activities related to the recognition of patents worldwide. We are the first company in Poland to market a modified-release hypotensive drug containing indapamide – Diuresin SR.

The Research and Development Division comprises:

• Specialists in medicine, chemistry, pharmacy and biotechnology
• Laboratories equipped with the newest laboratory and analytical equipment and machines for manufacturing ready-for-use drugs on a laboratory and pilot plant scale
• Work on high-quality products based on Good Manufacturing Practice and Good Laboratory Practice standards
• Scientific and knowledge-based cooperation with academic research centres

Our research focuses on the development of modern solutions in the following therapeutic areas:

• respiratory diseases
• gastrointestinal diseases
• metabolic diseases
• cardiology
• neurology
• dermatology
• gynaecology